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Abstract
BACKGROUND: In general, angiopoietin-2 levels are increased concomitantly with dengue clinical severity. 
AIM: This research aims to determine the role of mutation on angiopoietin-2 on dengue clinical severity.
METHODS: A cross-sectional study of 108 children with dengue disease grouped by severity. Angiopoietin-2 
level was examined by enzyme-linked immunosorbent assay. Polymerase chain reaction and double nucleic acid 
sequencing are using 2 Exon 4-F primers.
RESULTS: Angiopoietin-2 levels on rs7834131 mutant are higher in dengue fever (p < 0.05) and dengue hemorrhage 
fever group than non-mutant, while on dengue shock syndrome, it is lower than non-mutant.
CONCLUSION: Angiopoietin-2 mutation on rs7834131 might have a protective effect on dengue disease severity.
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Introduction
Dengue virus infection is still one of the major 
health problems worldwide. An estimated 50 million 
people infected each year with a death rate of 22,000 
per year [1]. Plasma leakage is a major factor that 
distinguishes the severity of the disease-causing 
dengue hemorrhagic fever (DHF) and dengue 
shock syndrome (DSS). There are many theories 
stating that many molecules play a role in causing 
endothelial damage that triggers vascular leakage. 
Vascular integrity and plasma leakage on dengue 
virus infection is affected by some factors such as 
(1) pro-inflammatory cytokines (TNF-α, IL1, IL-6, and 
IL-12) release from monocyte infected by dengue 
virus that will activate the endothelial cell [2]. These 
cytokines will increase the expression of adhesion 
molecule such as vascular cell adhesion-1 (VCAM-1), 
intercellular adhesion molecule-1 (ICAM-1), selectin, 
and ligand integrin [3] and [2] activation of angiogenic 
protein that affects the integrity of junctional 
endothelium, which are vascular endothelium growth 
factor (VEGF) and angiopoietin [4], [5] Angiopoietin-2 
level is reported to be the primary protein marker of 
plasma leakage on DHF and DSS [6], [7], [8]. The 
research of Li et al. shows that the genetic variation 
of ANGPT-2 is associated with an increased risk of 
developing ARDS [9].
A study in Haiti showed that although dengue 
infection is caused by multiple serotypes, none of 
which have DHF and DSS [10]. Research in Cuba 
has found that the severity of dengue infection is 
milder in blacks than in whites. Both of these have 
led to theories on the existence of genetic influences, 
in the form of mutations and polymorphisms that 
affect the severity of the disease due to dengue virus 
infection [11].
The angiopoietin-2 protein-coding gene is 
located on chromosome 8 and is a highly polymorphic 
gene. The genetic variation of angiopoietin-2 causes 
different variations in angiopoietin protein expression 
and vascular angiogenesis [6, 12, 13].
Angiopoietin-2 gene polymorphism research on 
dengue disease has not been done, so the researcher 
is interested to see the genetic role of angiopoietin-2 
gene polymorphism on the clinical severity of dengue 
disease on children.
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Materials and Methods
This was observational research using a 
cross-sectional design. The research population 
was patients diagnosed with dengue virus infection 
based on the World Health Organization (WHO) 2011 
clinical criteria with positive immunoglobulin M (IgM) 
anti-dengue or IgM and immunoglobulin G (IgG) anti-
dengue positive in the Pediatric Department of Dr. M. 
Djamil Padang/Faculty of Medicine Andalas University. 
The research conducted from August 2016 to June 
2017. Subjects were part of the population that meets 
the inclusion criteria. Inclusion criteria are patients 
aged 1 month–14 years old with consent collected 
from the parents to participate in the research, 
exclusion criteria are patients with expanded dengue 
syndrome.
Routine blood, IgM, and IgG anti-dengue were 
examined at the Clinical Pathology Laboratory of Dr. M. 
Djamil Padang. Examination of angiopoietin-2 level was 
performed by Enzyme-Linked Immunosorbent Assay 
using ANGPT-2 Kit, Ray Biotech. An examination of 
angiopoietin-2 polymorphism was initially started with 
genomic DNA isolation using genomic DNA Mini Kit. The 
DNA was extracted from each subject’s blood sample. 
For polymerase chain reaction and DNA sequencing, 
2 Exon 4-F primers were used, including forward 
5’-CACCCATATCCCACCTATCCT-3 ‘and reverse 
5’-TGCCCAGTCTCATCCTTCTA-3’ primer. The primer 
was synthesized by Integrated DNA Technologies, 
Singapore, which was designed based on the ANGPT-2 
Homo sapiens gene sequence (NCBI Accession No. 
NG_029483.1) as a template.
The data obtained were analyzed by the 
computer system and presented in the form of tables 
and graphs. Characteristics of research subjects 
related to the severity of dengue disease were tested 
with Chi-square and analysis of variance (ANOVA). 
Different independent variables with disease severity 
were tested with ANOVA, with a significance of p < 0.05.
This study had passed ethical clearance No. 
147/KEP/FK/2015 from the Committee of Ethics of 
Medical Faculty of Andalas University.
Results
Subjects characteristics
During the research periods, 121 subjects with 
dengue virus infection were selected by consecutive 
sampling. A total of 13 subjects were excluded due to 
insufficient blood sample volume in 6 subjects and lysis 
of the blood sample in 7 other subjects. There were 
108 total subjects who participated in the research, 
including DF in 34 subjects (31.48%), DHF in 39 
subjects (36.11%), and DSS in 35 subjects (32.40%). 
Demographic data and characteristics of subjects 
summarized in Table 1.
Table 1 showed the number of female subjects 
is 58 people (53.71%), with the most age is 5-10 years. 
There were no significant differences between sex 
and age in DF, DHF, and DSS. The median values 
of hemoglobin and hematocrit subjects increased 
significantly with the severity of the disease (p < 0.05). 
Post hoc tests of hemoglobin and hematocrit values 
showed significant differences between DF and DHF 
groups (p < 0.05), but no significant differences were 
found between DF and DSS group and between 
DHF and DSS group (p > 0.05). Platelet count was 
significantly lower in the DHF and DSS group compared 
to DF (p < 0.05). Post hoc test showed that there was 
a significant difference in platelet count significant DF 
and DHF group and between DF and DSS group (p < 
0.05), but there was no significant difference between 
DHF and DSS group (p > 0.05).
Association of angiopoietin-2 level with 
severity of dengue disease
Table 2 shows that the median level of 
angiopoietin-2 in the DSS group was higher than in 
the DHF group and the median level in the DHF group 
was higher than in the DF group. The differences in the 
levels of these three groups were statistically significant 
(p < 0.05). In the Mann-Whitney post hoc test, there 
was also a significant difference of angiopoietin-2 levels 
among all groups (between DF and DHF, DHF and 
DSS, as well as DF and DSS).
Table 1: Clinical characteristics and laboratory of research subjects based on dengue virus infection severity
Characteristic DF (n=34) DHF (n=39) DSS (n=35) p value
Clinical characteristic
Sex, n (%)
Male
Female
18 (52,9)
16 (47,1)
13 (33,3)
26 (66,7)
19 (54,3)
16 (45,7)
0,897a
Age, years old, mean (SD)
≤1
1–5
>5–10
>10
7.87 (3.59)
2
8
15
9
7.07 (3.25)
2
9
22
6
6,19 (4,06)
5
12
10
8
0,165b
0,344c
Laboratory characteristics
Hemoglobin (g/dl), Median (min–max) 12.2 (10.5–14.8) 13,3 (9,2-17,3) 13,5 (5,6-17,4) 0,010c
Hematocrit (%),  median (min-max) 37.5 (33–49) 41 (28-53) 41 (16-53) 0,016c
Platelet count, (/mm3),median 
(min-max)
78 500 (13.000–247.000) 40 000 (13.000- 133.000) 40 000 (4.000-131.000) 0,001c
aChi-square, bOne way ANOVA, cKruskal-Wallis.
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Angiopoietin-2 gene polymorphism
Angiopoietin-2 gene sequencing results were 
analyzed using the Geneious bioinformatics software. 
Number of SNPs with global minor allele frequency 
(GMAF) ≥0.01 registered in single nucleotide 
polymorphism database (dbSNP) of the National 
Center for Biotechnology (NCBI) is 7 SNPs, and 
after sequencing all of the samples, 10 SNPs were 
obtained. The 2 additional SNPs are SNP with GMAF 
< 0.01 and 1 new SNP with unknown (Figure 1). 
Figure 1 showed the characteristics of SNP found in 
ANGPT-2 gene sequencing, and it was found that as 
many as 5 SNPs were in exon 4, namely: 4c.46981, 
rs149699486, rs55633437, rs3020221, rs374966371, 
and 4 SNPs were in intron 3, that is, rs7834131, 
rs963495, rs145450899, rs115694540, and 1 SNP 
was in intron 4, which was rs963496. Gene 4c.46981 
is a new SNP that has not been registered in NCBI 
that is located on the order of base no 232 (marked 
with purple box).
Amino acid changes were also found in 
two other SNPs undergoing a mutation, that is, SNP 
rs149699486 (T/C) where valine amino acid become 
alanine (Val (V) 235Ala (A)) and SNP rs374966371 
(A/T) where asparagine become isoleucine (Asn (N) 
257Ile (I)). To detect the SNP in the sequencing result, 
the entire sequence of samples was aligned with the 
angiopoietin-2 reference gene (NG_029483.1) using 
multiple alignment with the help of Geneious software.
Association of angiopoietin-2 gene 
polymorphism with angiopoietin-2 level
The relationship between angiopoietin-2 gene 
polymorphism and angiopoietin-2 levels can be seen 
in Table 3. Only 5 SNPs can be statistically analyzed 
because in 2 other SNPs there are no mutations and 3 
SNPs have very few mutations.
Table 3 shows that the levels of angiopoietin-2 
in the rs7834131, rs115694540, 4c.46981, and 
rs3020221 mutant group were higher than the normal 
Table 2: Level of angiopoietin-2 in different severity disease
Dengue severity n Level of angiopoietin-2 (pg/ml) p value
Dengue fever (DF) 34 397,45 (64,48–1895,07) < 0.001
Dengue hemorrhage fever (DHF) 39 558,52 (79,36–2797,71)
Dengue shock syndrome (DSS) 35 1393,82 (58,52–6310,49)
Figure 1: Results of genes sequencing angiopoietin-2 exon 4 using designed primer. There was one new SNP that has not been registered in 
NCBI that is 4c.46981 located on the order of base to 232 (marked with red box). In this SNP mutation, allele A changed into allele G, the allele 
changes cause the amino acid to change resulting the alteration from lysine to glutamate (Lys (K) 232Glu (E))
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group, but the difference in levels was only significant 
at SNP rs7834131 (p<0.05).
Association of rs7834131 mutations with 
angiopoietin-2 level and dengue disease severity
Table 4 showed there was an increasing level 
of angiopoietin-2 on the DF group with mutations 
compare with non-mutations (wild type) and it is 
statistically significant (p < 0.05). The median value of 
angiopoietin-2 on the DHF group with mutations was 
higher than non-mutations (wild type), but it is not 
statistically significant. In the DSS group the median 
value of angiopoietin-2 levels with mutations was lower 
than non-mutations but it is not statistically significant 
(p > 0.05).
Table 4: Association of rs7834131 mutation with angiopoietin-2 
levels on dengue disease severity
Group n = 108 Angiopoietin-2 levels (pg/ml)
Median (minimum-maximum)
p value
DF Mutan 5 1477.36 (112.09-1895.07) 0.044
Normal (Wild type) 29 263.88 (64.48-965.93)
DHF Mutan 8 798.43(209.9-1179.88) 0.543
Normal (Wild type) 31 558.519 (79.36-2797.71)
DSS Mutan 10 1303.15(597.13-2567.47) 0.855
Normal (Wild type) 25 1503.85 (58.52-6310.49)
Discussion
Clinical characteristics of subjects, including 
sex and age, did not differ significantly among the 
three groups. The group of the age of 5–10 years old 
was the most affected age group in this research. This 
is in accordance with the research by Sumarmo and 
Mayetti [14], [15].
This research showed no association between 
disease severity and gender. Research by Ditjen PP 
and PL of Indonesian Health Department in 2008 and 
Sumarmo also showed the same result where there 
was no gender difference in children with dengue virus 
infection [14], [16].
This research found that there were significant 
differences in hemoglobin, hematocrit, and platelet 
levels among the three groups. A significant difference 
in hematocrit levels indicated a plasma leakage in the 
more severe disease group that leads to hypovolemic 
shock [17].
We also found that the platelet count was 
significantly lower in the more severe disease group 
(DHF and DSS). Thrombocytopenia leads to low 
levels of angiopoietin-1 because angiopoietin-1 was 
also present in large amounts in platelets. A low level 
of angiopoietin-1 causes an imbalance between 
angiopoietin-1 and angiopoietin-2 levels that play a role 
in plasma leakage. The results from this research are 
similar to those obtained by Rampengan who reported 
that angiopoietin-2 was instrumental in the pathogenesis 
of transient vascular leakage in DHF, an increase 
in angiopoietin-2 caused the instability of the blood 
vessels leading to increased vascular permeability that 
eventually led to the occurrence vascular leak.6 This 
research found there was a significantly higher level of 
angiopoietin-2 in the DSS group than the DHF group 
and a significantly higher level of angiopoietin-2 in the 
DHF group than the DF group.
The examination of angiopoietin-2 gene 
polymorphism in this research focused on exon region 4. 
The reason for choosing exon 4 was a region that has 
been widely studied since it is a highly polymorphic 
area. Ward et al. reported that the angiopoietin-2 gene 
had a high degree of polymorphism [18]. Another 
research used prime exon 4 to detect angiopoietin-2 
gene polymorphism on different diseases. In addition, 
the exon region 4 had more SNPs than any other region 
with a relatively large minor allele frequency [19], [20].
We performed the sequencing from intron 
3, exon 4 to intron 4. The sequencing result showed 
polymorphism on 8 of 10 SNPs that persisted throughout 
the region. Nine SNPs examined were old SNPs that 
were already known, and we also found 1 new SNP 
that has not been registered in NCBI, namely, 4c.46981 
located in exon 4 on the sequence of base no. 232.
Mutation on genotype A/G in rs7834131 related 
with increasing of angiopoietin-2 levels significantly in 
children with dengue virus infection. Angiopoietin-2 level 
in mutation group was higher than non-mutations group, 
and this difference is statistically significant. Effect of 
A/G mutation toward increasing of angiopoietin-2 levels 
clearly visible on DF group, where 4 of 5 subjects with 
mutations in DF group have angiopoietin-2 levels above 
group median value, in addition, 3 of them also has the 
highest extreme value in DF group on subject 3, 13, 
and 32.
Further analysis showed that A/G mutation 
on rs7834131 caused a significant increase of 
angiopoietin-2 levels in the DF group; meanwhile, 
in the DHF group, this increment is not statistically 
significant. On the contrary, angiopoietin-2 levels in 
DSS with the mutation group clearly lower than non-
mutation even though the differences are statistically 
significant. It proved that increasing angiopoietin-2 
levels due to mutation of A/G in rs7834131 might have 
Table 3: Relation of angiopoietin-2 gene polymorphism with 
angiopoietin-2 levels
SNP Allele n = 108 Angiopoietin-2 levels (pg/ml)
Median (minimum-maximum)
p-value
rs7834131 Mutan 23 1075.962 (112.09–2567.49) 0,012
Normal (Wild type) 85 550.26 (58.52–6310.49)
rs115694540 Mutan 9 1020.95 (88.29–1561.49) 0,645
Normal (Wild type) 99 597.13 (58.52–6310.49)
4c.46981 Mutan 9 1020.95 (88.29–1561.49) 0,645
Normal (Wild type) 99 597.13 (58.52–6310.49)
rs55633437 Mutan 16 556.38 (79.36–2848.65) 0,318
Normal (Wild type) 92 603.24 (58.52–6310.49)
rs3020221 Mutan 38 887.48 (109.12–3845.02) 0,073
Normal (Wild type) 70 554.39 (58.52–6310.49)
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a protective effect to prevent leakage. It means that the 
higher the level of angiopoietin-2 due to mutation on 
rs7834131, the more protection it has toward plasma 
leakage, thus decreasing the severity of the disease. 
This is probably due to the mutation causing functional 
changing of angiopoietin-2, where even though the 
amount released still high, but the ability of bonding 
with the Tie-2 receptor was interrupted.
Some previous studies had varied results about 
the role of genetic factors in dengue virus infection. 
Single nucleotide polymorphism examination in the 
MBL2, TNF-a, Fcy gene receptors, CTLA-4, TGF-b1, 
HPA, DC-SIGN, TAP, VDR, and JAK1 were associated 
with the level of protection, susceptibility, and severity 
of dengue infection, while SNP examination in IL-4, 
IL-1RA, IFN-y, IL-genes 6, TLR4, and IL-10 were not 
related to the severity of dengue virus infection [21].
To date, this research was probably the first 
to examine the genetic polymorphism/mutation of 
the angiopoietin-2 gene in pediatric patients infected 
with the dengue virus. However, in some studies, G/A 
mutations were not associated with the incidence of type 
2 DM. Pietrowski et al. obtained G/A polymorphisms 
on exon-4 angiopoietin-2 genes were not associated 
with the incidence of idiopathic recurrent miscarriages 
in white female populations in Central Europe [19]. 
G/A polymorphisms were also not associated with 
the incidence of intrauterine fetal distress (IUFD) in 
Caucasian populations [22], and also not associated 
with an increased risk of gynecological cancer in 
Turkey [23].
The severity of the disease due to dengue 
virus infection was determined by the severity of 
plasma leakage that occurs. The process of plasma 
leakage begins from endothelial injury and involves 
the interaction of other factors that are very complex. 
The results of this research indicated that the presence 
of an A/G mutation at rs7834131 was associated 
with an increase in levels of angiopoietin-2, but this 
mutation was not related to the severity of the disease. 
This reinforces the notion that the A/G mutation at 
rs7834131 might be protective against plasma leakage. 
There were other factors that were not examined in 
this research that may cause an increase in the levels 
of angiopoietin-2 which play a more role in triggering 
plasma leakage in patients with dengue virus infection.
The effect of plasma leakage due to 
angiopoietin-2 will occur only if angiopoietin-2 binds to 
the Tie-2 receptor so that subsequent cascade activation 
occurs. Some studies also show plasma leakage can 
be prevented if the Tie2 receptor is occupied by ligands 
other than angiopoietin-2, or there is a deletion of 
angiopoietin-2 genes [24]. In this research, we found 
that patients with rs7834131 mutation also had an 
increment in angiopoietin-2 levels in the DF group, 
but this increase did not cause plasma leakage. It is 
suspected that mutations not only cause an increase 
in angiopoietin-2 level but also change the structure of 
angiopoietin-2 so that it is not effective to bind to the 
Tie-2 receptor as a result of heparanase release and 
the structure of the glycocalyx remains intact. Kumpers 
et al. found that protection against plasma leakage was 
given by exogenous Tie-2 stimulation, angiopoietin-2, 
or genetic deletions of angiopoietin-2 in various models 
of sepsis partly due to the defense of glycocalyx [25].
In conclusion, gene polymorphism found in 
children with dengue virus infection. Angiopoietin-2 
gene mutation at rs7834131 has been assumed to 
have a protective effect on the severity of the disease 
due to dengue virus infection in children.
Acknowledgments
This research was supported by Andalas 
University, Padang. We thank our colleagues from the 
Department of Pediatrics, Andalas University, Padang, 
Indonesia, who provided insight and expertise that 
greatly assisted the research.
References
1. World Health Organization. Comprehensive Guidelines 
for Prevention and Control of Dengue and Dengue 
Hemorrhagic Fever. Geneva: South East Asia Regional 
Office, World Health Organization; 2011. https://doi.
org/10.1079/9781845939649.0168
2. Dalrymple NA, Mackow ER. Roles for endothelial cells in 
dengue virus infection. Adv Virol. 2012;2012:840654.
 PMid:22952474
3. Whalen MJ, Doughty LA, Carlos TM, Wisniewski SR, 
Kochanek PM, Carcillo JA. Intercellular adhesion molecule-1 
and vascular cell adhesion molecule-1 are increased in 
the plasma of children with sepsis-induced multiple organ 
failure. Crit Care Med. 2000;28(7):2600-7. https://doi.
org/10.1097/00003246-200007000-00070
 PMid:10921602
4. Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, 
Karumanchi SA, et al. Excess circulating angiopoietin-2 may 
contribute to pulmonary vascular leak in sepsis in humans. 
PLoS Med. 2006;3(3):e46. https://doi.org/10.1371/journal.
pmed.0030046
 PMid:16417407
5. Gavard J, Patel V, Gutkind JS. Angiopoietin-1 prevents VEGF-
induced endothelial permeability by sequestering Src through 
mDia. Dev Cell. 2008;14(1):25-36. https://doi.org/10.1016/j.
devcel.2007.10.019
 PMid:18194650
6. Rampengan NH, Daud D, Waraouw S, Ganda IJ. Serum 
angiopoeitin 2 as marker of plasma leakage in dengue viral 
infection. Am J Clin Exp Med. 2015;3:39-43.
7. Hawkes M, Rajwans N, Conroy AL, Gélvez M, Tran V, Liles WC, 
et al. Host biomarkers are associated with progression to dengue 
haemorrhagic fever: A nested case-control study. Int J Infect 
 Mayetti et al. Gene mutation value on disease severity
Open Access Maced J Med Sci. 2020 Oct 30; 8(B):1110-1115. 1115
Dis. 2015;40:45-53. https://doi.org/10.1016/j.ijid.2015.07.027
 PMid:26255888
8. Mariko R, Darwin E, Yanwirasti Y, Hadinegoro SR. The 
difference of angiopoietin-2 levels between dengue hemorrhagic 
fever patients with shock and without shock. Open Access 
Maced J Med Sci. 2019;7(13):2119-22. https://doi.org/10.3889/
oamjms.2019.569
 PMid:31456836
9. Li S, Zhai R, Sheu CC, Gallagher DC, Gong MN, Tejera P, et al. 
Genetic variants in the angiopoietin-2 gene are associated with 
increased risk of ARDS. Intensive Care Med. 2009;35(6):1024-
30. https://doi.org/10.1007/s00134-009-1413-8
 PMid:19271210
10. Halstead SB, Streit TG, Lafontant JG, Putvatana R, Russell K, 
Sun W, et al. Haiti: Absence of dengue hemorrhagic fever despite 
hyperendemic dengue virus transmission. Am J Trop Med Hyg. 
2001;65(3):180-3. https://doi.org/10.4269/ajtmh.2001.65.180
 PMid:11561700
11. Kourí G, Guzmán MG, Valdés L, Carbonel I, del Rosario D, 
Vazquez S, et al. Reemergence of dengue in Cuba: A 
1997 epidemic in Santiago de Cuba. Emerg Infect Dis. 
1998;4(1):89-92. https://doi.org/10.3201/eid0401.980111
 PMid:9454563
12. Michels M, Van der Ven AJ, Djamiatun K, Fijnheer R, 
De Groot PG, Griffioen AW, et al. Imbalance of angiopoietin-1 
and angiopoetin-2 in severe dengue and relationship with 
thrombocytopenia, endothelial activation, and vascular stability. 
Am J Trop Med Hyg. 2012;87(5):943-6. https://doi.org/10.4269/
ajtmh.2012.12-0020
 PMid:22949515
13. Van de Weg CA, Pannuti CS, Van den Ham HJ, De Araújo ES, 
Boas LS, Felix AC, et al. Serum angiopoietin-2 and soluble 
VEGF receptor 2 are surrogate markers for plasma leakage 
in patients with acute dengue virus infection. J Clin Virol. 
2014;60(4):328-35. https://doi.org/10.1016/j.jcv.2014.05.001
 PMid:24928471
14. Sumarmo PS. Infeksi virus dengue. In: Sumarmo PS, Garna H, 
Hadinegoro SR, editors. Buku Ajar Ilmu Kesehatan Anak 
Dan Penyakit Tropis. 1st ed. Jakarta: Balai Penerbit Fakultas 
Kedokteran Universitas Indonesia; 2002. p. 176-208.
15. Mayetti M. Hubungan gambaran klinis dan laboratorium 
sebagai faktor risiko syok pada demam berdarah dengue. 
Sari Pediatr. 2010;11(5):367-77. https://doi.org/10.14238/
sp11.5.2010.367-73
16. Kementerian Kesehatan Republik Indonesia, Laporan 
Akuntabilitas Kinerja Ditjen PP Dan PL Tahun. Direktorat 
Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan. 
Jakarta: Kementerian Kesehatan Republik Indonesia; 2012. 
https://doi.org/10.22236/psd/11104-11764
17. Jessie K, Fong MY, Devi S. Localization of dengue virus in 
naturally infected human tissues, by immunohistochemistry and 
in situ hybridization. J Infect Dis. 2004;189(8):1411-8. https://
doi.org/10.1086/383043
 PMid:15073678
18. Ward EG, Grosios K, Markham AF, Jones PF. Genomic 
structures of the human angiopoietins show polymorphism in 
angiopoietin-2. Cytogenet Cell Genet. 2001;94(3-4):147-54. 
https://doi.org/10.1159/000048807
 PMid:11856872
19. Pietrowski D, Tempfer C, Bettendorf H, Bürkle B, Nagele F, 
Unfried G, et al. Angiopoietin-2 polymorphism in women with 
idiopathic recurrent miscarriage. Fertil Steril. 2003;80(4):1026-
9. https://doi.org/10.1016/s0015-0282(03)01011-2
 PMid:14556828
20. Onen HL, Konac E, Eroglu M, Ekmekci A. Angiopoeitin-2 
gene polymorphism in sporadic prostate cancer. Gazi Med J. 
2007;18:121-6.
21. Harapan H, Fajar JK, Wahyuniati N, Anand JR, Nambaru L, 
Jamil KF. Non-HLA gene polymorphisms and their implications 
on dengue virus infection. Egypt J Med Hum Genet. 
2003;14(1):1-11. https://doi.org/10.1016/j.ejmhg.2012.08.003
22. Hubert A, Grimm C, Pietrowski D, Zeillinger R, Bettendorf H, 
Husslein P, et al. An angiopoietin-2 gene polymorphism in 
unexplained intrauterine fetal death: A multi-center study. J 
Reprod Immunol. 2005;65(1):47-53. https://doi.org/10.1016/j.
jri.2004.12.001
 PMid:15694966
23. Konac E, Onen HI, Metindir J, Alp E, Biri AA, Ekmekci A. Lack 
of association between -460 C/T and 936 C/T of the vascular 
endothelial growth factor and angiopoietin-2 exon 4 G/A 
polymorphisms and ovarian, cervical, and endometrial cancers 
DNA Cell Biol. 2007;26(7):453-63. https://doi.org/10.1089/
dna.2007.0585
 PMid:17630849
24. Lukasz A, Hillgruber C, Oberleithner H, Kusche-
Vihrog K, Pavenstädt H, Rovas A. Endothelial glycocalyx 
breakdown is mediated by angiopoietin-2. Cardiovasc Res. 
2017;113(6):671-80. https://doi.org/10.1093/cvr/cvx023
 PMid:28453727
25. Kumpers P, Gueler F, David S, Slyke PV, Dumont DJ, Park JK, 
et al. The synthetic tie2 agonist peptide vasculotide protects 
against vascular leakage and reduces mortality in murine 
abdominal sepsis. Crit Care Med. 2011;15(5):R261. https://doi.
org/10.1186/cc10523
 PMid:22040774
